Lannett Company Inc. recalls Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Phi
Recalled March 20, 2019 · FDA recall D-0996-2019 · Lannett
Hazard
Failed Dissolution Specifications · FDA Class III
Units
14,448 bottles
Sold at
Nationwide, including Puerto Rico.
Description
Failed Dissolution Specifications
Product
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Manufacturer(s)
Lannett Company Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →